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Abstract: Background: Nasopharyngeal carcinoma (NPC) is a tumor arising from the epithelial cells that cover the 
surface and line the nasopharynx. NPC is a relatively rare malignancy in most parts of the world but it is endemic in many 
geographical regions, including Southern China, Southeast Asia and the Middle East/North Africa., Indonesia in 
particular, the incidence is relatively high, ranks 5
th
 out of 10 large tumors of the body and ranks 1
st
 in our department. 
Objective: To study the relationship between the expressions of LMP1 and VEGFR (Flt-4) proteins compared with 
staging and histopathological features of nasopharyngeal carcinoma (NPC) in Indonesian population. 
Materials and Methods: A cross sectional study with explorative approached was conducted in Makassar-Indonesia from 
July 2006 to August 2007. The expression of VEGFR (Flt-4) and LMP-1 proteins was examined by immuno 
histochemical with avidin-biotin methods staining in 45 NPC specimens. 
Result: VEGFR (Flt-4) and LMP-1 were expressed in 100% and 42,1% of NPC specimens. No significant difference in 
correlation (p>0,05) between staging with VEGFR(Flt-4) and LMP-1 expression, these results indicated that VEGFR(Flt-
4) and LMP-1 were expressed during early stage to prepare for enhancing metastatic capacity to the later stage of NPC. 
There was negative correlation (p<0,05) between histopathological classification with VEGFR(Flt-4) and LMP-1 
expression, this indicated that the expression of VEGFR(Flt-4) and LMP-1 was much higher in WHO type II (well 
differentiated) than WHO type III (undifferentiated). WHO type II well-known as more less sensitive to radiotherapy than 
WHO type III, according to the prognostic value; WHO type III better than type II. There was strong positive correlation 
(r= 0,990, p<0,05) between LMP-1 with VEGFR(Flt-4) expression, thereby LMP-1 induces production or expression of 
VEGF. No significant correlation was found between staging and histopathological features, VEGFR(Flt-4) and LMP-1 
expression with alcohol, smoking, betel leaves-areca nuts, air pollution (wood’s fire stove, mosquito repellent’s smoke) 
and preservative foods (salted fish, canned food and smoked meat). 
Conclusion: These results suggest that both VEGFR (Flt-4) and LMP-1 expressions are valuable prognostic markers for 
prognostic prediction in NPC patients. 
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INTRODUCTION 
 Nasopharyngeal carcinoma (NPC) is a tumor arising 
from the epithelial cells that cover the surface and line the 
nasopharynx. NPC is a relatively rare malignancy in most 
parts of the world but it is endemic in many geographical 
regions, including Southern China, Southeast Asia and the 
Middle East/North Africa [1-3]. Ho [1] reported that NPC is 
the third most common malignancy among men, with an 
incidence of between 50 per 100,000 in the Guangdong 
Province of Southern China. Incidence is higher in the 
Chinese and Tunisian populations. NPC in Indonesia ranks 
5
th
 out of 10 large tumors of the body and ranks 1
st
 in our 
ENT department. Nations with high risk are Eskimo, 
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Tunisia, Philippines, Malaysia, Algeria and Indonesia. 
Rarely found in Caucasian, India, and Japan [2-4]. In 
Indonesia the incidence to date is not known. Health 
department data in 1980 showed the prevalence was 4.7 in 
100.000 or estimated 7,000 to 8,000 cases in a year [5]. 
Profile data of nasopharyngeal carcinoma in Hasanuddin 
University Hospital Makassar, Indonesia from period of 
January 2000 to June 2007 revealed that nasopharyngeal 
carcinoma covered 33% malignancy of ear, nose, and throat. 
Majority in 4
th
 and 5
th
 decades of life, male to female ratio is 
2-3:1, the main histopathology finding was anaplastic 
carcinoma (type III WHO) accompanied by high tendency of 
metastasis [6]. 
 NPC is often overlooked due to variation of symptoms 
and sign as well as difficulty to examine nasopharyngeal 
space, especially in Rosenmuller fossa, which is taken from 
the inventor, a German anatomist, Johan Christian 
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Rosenmuller. Therefore, mortality rate is high. Patients 
usually come for treatment when the malignancy has 
developed to 3
rd
 degree or more. The range of life 
expectancy of 10 years range is 10 % [7-9]. 
 One of the risk factors that contributes to the process of 
somatic cell malignancy process is gene mutation. This 
mutation is caused by viral infection, radiation, and 
carcinogenic substances. The effect of gene mutations is 
uncontrolled cell proliferation and cell immortalization. Ebstein-
Barr Virus (EBV), as the name of the founder M. Anthony 
Epstein, Yvonne Barr, and B.G Achong in 1964, in cell cultured 
from Burkitt tumor. This virus originates from herpesviridae 
family, gamma herpes virus subfamily, lymphocryptovirus 
genera. Epstein-Barr Virus can be detected using serology, cell 
culture, and DNA technology [3, 4, 10-13]. 
 Latent Membrane Protein-1 (LMP-1) products integral 
membrane (oncoprotein). LMP-1 gene is found in 65% 
nasopharyngeal carcinoma patients. LMP-1 EBV induces 
expression of COX-2 (cyclooxygenase) facilitated by NF?B 
using CTAR1 and CTAR2 (carboxyl terminal activation region) 
on nasopharyngeal epithelial cell, producing Prostaglandin E2 
and initiates increased production of Vascular Endothelial 
Growth Factor (VEGF) which plays a role in angiogenesis and 
lymphangiogenesis of NPC patients. VEGF-C is an important 
regulator of angiogenesis and lymphangiogenesis in the 
development, growth, and metastasis of malignant tumors 
including nasopharyngeal carcinoma. Some studies showed 
increased expression of VEGFR (Flt-4) which is a receptor of 
VEGF-C and associated with angiogenesis and lymphangio-
genesis gradation, and poor prognosis in several human cancer 
[14-17]. Therefore, this research is conducted to find the 
potential relationship of VEGFR (Flt-4) and LMP-1 EBV 
expression on malignant tissue against stage, histopathology 
finding of nasopharyngeal carcinoma. Therefore a new more 
accurate treatment may be developed to reduce mortality and 
improved prognosis prediction 
RESEARCH OBJECTIVES 
 To study the LMP-1 EBV and VEGF gene role on 
pathophysiology and NPC prognosis, expression of LMP-1 
EBV and VEGFR (Flt-4) gene on NPC biopsy specimen and 
its correlation to Staging (TNM-UICC 2002) and histopatho-
logy findings (WHO 1979). 
MATERIALS AND METHODS 
 This research is a cross sectional using explorative 
approach, conducted in Hasanuddin University hospital 
Makassar-Indonesia, Research unit and Department of 
Anatomical Pathology, Medical Faculty Gajah Mada University 
Jokjakarta from July 2006 to August 2007 Archival formalin-
fixed, paraffin-embedded specimens from 45 primary NPC 
patients were recruited. Tumors from the paraffin blocks were 
underwent tissue microarray construction before 
immunostaining. Paraffin sections were directly dissected for 
pathological staining and immunohistochemistry. 
 This study was approved by the Ethical Review Board of 
Medical Faculty Hasanuddin University. 
Clinical Examination 
 A detailed history was considered using standardized 
questionnaire including race, age, gender, complained, first 
sign, habits of alcohol, smoking, betel quid chewing, salted 
fish, canned food, smoked meat, smoked mosquitoes 
repellent, wood smoke and family history. 
 Physical examination was performed for each patient 
including: ear, nose, and throat examination and 
nasoendoscopy assessment. And we complete the assessment 
was completed with biopsy, histopathology, chest x-ray, CT-
scan, bone-survey, and abdomen ultrasonography. 
 The inclusion criterion was the final finding of 
examination and assessments. 
Immunohistochemistry Examination 
 Positive paraffin block biopsy of NPC cut with 5 ?m 
thickness and placed in a glass object (precleaned white 
glass with poly L lysine coated) and left for one night in 37-
40°C incubator. Then the specimen underwent de-paraffin. 
Immunohistochemistry examination conducted using anti-
VEGFR (FLT-4 monoclonal antibody (Lab. Viscon) (1:200). 
For LMP-EBV, anti-LMP-1 EBV monoclonal antibody 
(Novo Castra) (1:200) was used. Based on avidin-biotin-
peroxidase technique. 
 Positive expression of LMP-1 was seen as brown granula 
on cytoplasma and membrane, while on VEGFR was seen as 
brown granule on cytoplasma. Expression measurement was 
conducted using binocular microscope magnified to 100-200 
times on random field view and counted in 100-200 cells. 
Semi quantitative measurements of VEGFR(Flt-4) and LMP-
1 expression are; 0:negative, 1+: weak (<10% of expression), 
+2: moderate (10-25%), and +3: strong (expression>25%). 
RESULTS 
Sample Characteristic 
 Sample characteristic can be seen in Table 1. Sample 
mean age was 45,8 ± 13,7 years old, the youngest was 17 
years old and the oldest was 72 years old. There were 38 
male (84.4%) and 7 female (15.6%). The main races were 
Bugis 21 (46.7%), and Makassar 12 (26.6%). The first most 
first complained were nose bleeding in 16 (35.56%), and 
headache in 9 (20%). The most complained were neck mass 
in 24 (53.3%) and nasal obstruction in 10 (22.2%) 
Nasopharyngeal Carcinoma Staging 
 Nasopharyngeal carcinoma staging is based on TNM-
UICC 2002 [18]in Table 2. Most stage found were stage III: 
19 cases (42.2%), stage IV: 14 cases (31.2%) 
Histopathology Finding 
 Histopathology finding based on WHO 1979 [8] in Table 
3, Type II WHO: 15 cases (33.3%), and Type III WHO: 30 
cases (66.7%). 
VEGFR(Flt-4) and LMP-1 Expression 
 The expression of LMP-1 (Fig. 1) and VEGFR (FLt-4) 
(Fig. 2) on nasopharyngeal biopsy was found in 41,1% in 
type III WHO and almost 100% LMP-1 (Fig. 3) and VEGFR 
(Flt-4) (Fig. 4) in type II WHO respectively. 
DISCUSSION 
 There was no significant correlation found between NPC 
staging and expression of VEGFR(Flt-4) and LMP-1  
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(p>0.05), which means that the expression of VEGFR(flt-4) 
and LMP-1 expression is higher on early stage, which is 
required for preparing metastasis. There were significant 
inverse relationship between histopathology and 
VEGFR(Flt-4) and LMP-1 expression (P<0.05), which 
means that the expression of VEGFR(Flt-4) and LMP-1 
expression is higher in type II WHO (Figs. 3, 4) (good 
differentiation) compared to type III WHO (poor 
differentiation), where the prognosis of type II WHO based 
on tumor response against radiation therapy is poorer than  
type III WHO. There was strong relationship (p<0.05) 
between VEGFR(Flt-4) and LMP-1 expressions, which 
means that LMP-1 expression increased as the expression of 
VEGFR(Flt-4) increased, therefore LMP-1 may increase 
(strong regulator) production of VEGFR(Flt-4). There was 
no significant relationship (p<0.05) between clinical findings 
including staging, histopathology, VEGFR(Flt-4) and LMP-
1 expression against alcohol, cigarette smoking, betel-quid 
chewing, pollutant (smoked mosquitoes repellent and wood 
smoke) and preserved food (salted fish, canned food, and 
smoked meat). 
Table 1. Sample Characteristic 
 
Group 
Characteristic 
Cases % Control % Total % 
Gender 
Male  38 84.44 28 62.22 66 73.33 
Female 7 15.56 17 37.78 24 26.67 
Total  45 100.00 45 100.00 90 100.00 
Age (Years) 
< 27 4 8.89 5 11.11 9 10.00 
27 - 36 8 17.78 17 37.78 25 27.78 
37 - 46 12 26.67 12 26.67 24 26.67 
47 - 56 9 20.00 7 15.56 16 17.78 
57 - 66 10 22.22 3 6.67 13 14.44 
> 66 2 4.44 1 2.22 3 3.33 
Total 45 100.00 45 100.00 90 100.00 
Race 
Bugis 21 46.67 16 35.56 37 41.11 
Makassar 12 26.67 11 24.44 23 25.56 
Toraja 6 13.33 3 6.67 9 10.00 
Gorontalo 2 4.44 2 4.44 4 4.44 
Mandar 1 2.22 4 8.89 5 5.56 
Minahasa 1 2.22 0 0.00 1 1.11 
Banjar 1 2.22 0 0.00 1 1.11 
Java 1 2.22 2 4.44 3 3.33 
Ambon 0 0.00 4 8.89 4 4.44 
Bali 0 0.00 2 4.44 2 2.22 
Chinese 0 0.00 1 2.22 1 1.11 
Jumlah 45 100.00 45 100.00 90 100.00 
 
CONCLUSION 
 LMP-1 is a strong regulator to VEGFR(Flt-4), associated 
with the prognosis of NPC, marked with the expression on 
type II WHO compared to type III WHO. Although there 
were no correlation between clinical finding including 
staging, histopathology finding, VEGFR(Flt-4) and LMP-1 
expression. 
Table 2. Staging of Nasopharyngeal Carcinoma 
 
Based on Stage (T, N, M-UICC 2002) Total % 
Stage I 2 4.44 
Stage II  
  II A 2 4.44 
  II B 8 17.78 
Stage III 19 42.22 
Stage IV 
  IV A 5 11.11 
  IV B 6 13.33 
  IV C 3 6.67 
Total 45 100.00 
 
Table 3. Histopathology Finding 
 
Histopathology Finding Total % 
Type 3 WHO 30 66.67 
Type 2 WHO 15 33.33 
Type 1 WHO 0 0.00 
Total 45 100.00 
 
 
Fig. (1). Expression of LMP-1, 200x, WHO3, St.IVC. 
 
Fig. (2). Expression of VEGFR (Flt-4), 200x, WHO3, St.IVC. 
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Fig. (3). Expression of LMP 1, 200x, WHO2, St II B. 
 
Fig. (4). Expression of VEGFR(Flt-4)200x, WHO2, St IIB. 
SUGGESTION 
 Wide research using larger sample covering various 
aspects that affect prognosis and multidisciplinary work. The 
expression of VEGFR(Flt-4) and LMP-1 expression can be 
considered as one predictor of NPC prognosis. 
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